Evidence map›Paper›PMID 29318202›Full record

ReviewSynthetic and systems biotechnology2017

Fundamental CRISPR-Cas9 tools and current applications in microbial systems.

Pingfang Tian, Jia Wang, Xiaolin Shen, Justin Forrest Rey, Qipeng Yuan, Yajun Yan

Abstract readReview
In one paragraph

Review in Synthetic and systems biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Harnessing the evolving CRISPR/Cas9 for precision oncology.Journal of translational medicine · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Heterologous production of cyanobacterial compounds.Journal of industrial microbiology & biotechnology · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli.World journal of microbiology & biotechnology · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. CRISPR-Cas9/Cas12a biotechnology and application in bacteria.Synthetic and systems biotechnology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pingfang TianCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Jia WangCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Xiaolin ShenCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Justin Forrest ReyCollege of Engineering, The University of Georgia, Athens, GA 30602, USA.
Qipeng YuanCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Yajun YanCollege of Engineering, The University of Georgia, Athens, GA 30602, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Derived from the bacterial adaptive immune system, CRISPR technology has revolutionized conventional genetic engineering methods and unprecedentedly facilitated strain engineering. In this review, we outline the fundamental CRISPR tools that have been employed for strain optimization. These tools include CRISPR editing, CRISPR interference, CRISPR activation and protein imaging. To further characterize the CRISPR technology, we present current applications of these tools in microbial systems, including model- and non-model industrial microorganisms. Specially, we point out the major challenges of the CRISPR tools when utilized for multiplex genome editing and sophisticated expression regulation. To address these challenges, we came up with strategies that place emphasis on the amelioration of DNA repair efficiency through CRISPR-Cas9-assisted recombineering. Lastly, multiple promising research directions were proposed, mainly focusing on CRISPR-based construction of microbial ecosystems toward high production of desired chemicals.

Indexed as

CRISPR activationCRISPR-Cas9CRISPR interferenceDNA repairHomologous recombination

Identifiers

PMID29318202
PMCPMC5655352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.